Nyxoah S.A.
NYXH
Cena:
$ 2.87
0.00 (0.00%)
Valuace
100
Růst
30
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
NYXOAH INVESTS IN FURTHER EXPANDING ITS BELGIAN MANUFACTURING CAPACITY TO SUPPORT ITS WORLDWIDE GROWTH
21-01-2026
NYXOAH INVESTS IN FURTHER EXPANDING ITS BELGIAN MANUFACTURING CAPACITY TO SUPPORT ITS WORLDWIDE GROW...
Více zde
PUBLICATION RELATING TO TRANSPARENCY NOTIFICATION
12-01-2026
REGULATED INFORMATION PUBLICATION RELATING TO TRANSPARENCY NOTIFICATION MONT-SAINT-GUIBERT (BELGIUM)...
Více zde
NYXOAH ANNOUNCES ISSUANCE OF FIRST TRANCHE OF CONVERTIBLE BONDS
19-12-2025
NYXOAH ANNOUNCES ISSUANCE OF FIRST TRANCHE OF CONVERTIBLE BONDS MONT-SAINT-GUIBERT, BELGIUM – DECE...
Více zde
NYXOAH ANNOUNCES COMMERCIAL LAUNCH OF GENIO® BREAKTHROUGH THERAPY IN THE NETHERLANDS
17-12-2025
NYXOAH ANNOUNCES COMMERCIAL LAUNCH OF GENIO® BREAKTHROUGH THERAPY IN THE NETHERLANDS FIRST GENIO ...
Více zde
PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS
02-12-2025
REGULATED INFORMATION PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS MONT-SAINT-GUIBERT (BELGIUM...
Více zde
NYXOAH TO PARTICIPATE IN THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE
27-11-2025
NYXOAH TO PARTICIPATE IN THE PIPER SANDLER 37 TH ANNUAL HEALTHCARE CONFERENCE...
Více zde
NYXOAH'S GENIO® THERAPY RECEIVES SIGNIFICANT 2026 MEDICARE REIMBURSEMENT INCREASES UNDER FINAL CMS RULE
26-11-2025
NYXOAH'S GENIO® THERAPY RECEIVES SIGNIFICANT 2026 MEDICARE REIMBURSEMENT INCREASES UNDER FINAL CMS ...
Více zde
INFORMATION ON THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
20-11-2025
REGULATED INFORMATION INFORMATION ON THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MONT-SAINT-GUIBERT...
Více zde
NYXOAH SECURES FINANCING COMMITMENTS OF UP TO U.S. $77 MILLION TO DRIVE U.S. COMMERCIALIZATION OF GENIO
13-11-2025
INSIDE INFORMATION REGULATED INFORMATION NYXOAH SECURES FINANCING COMMITMENTS OF UP TO U.S. $77 MILL...
Více zde
NYXOAH REPORTS THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
13-11-2025
REGULATED INFORMATION NYXOAH REPORTS THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS US LAUNCH OF...
Více zde
NYXOAH TO PARTICIPATE IN THE STIFEL 2025 HEALTHCARE CONFERENCE
03-11-2025
NYXOAH TO PARTICIPATE IN THE STIFEL 2025 HEALTHCARE CONFERENCE MONT-SAINT-GUIBERT, BELGIUM – NOVEM...
Více zde
NYXOAH TO RELEASE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
30-10-2025
NYXOAH TO RELEASE THIRD QUARTER 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025...
Více zde
NYXOAH ANNOUNCES FIRST U.S. COMMERCIAL PATIENTS IMPLANTED WITH GENIO® SYSTEM
06-10-2025
NYXOAH ANNOUNCES FIRST U.S. COMMERCIAL PATIENTS IMPLANTED WITH GENIO® SYSTEM EARLY COMMERCIAL LAUNC...
Více zde
PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS
03-10-2025
REGULATED INFORMATION PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS MONT-SAINT-GUIBERT (BELGIUM...
Více zde
NYXOAH PROVIDES AN UPDATE ON EXPANDED MIDDLE EAST PRESENCE
23-09-2025
NYXOAH PROVIDES AN UPDATE ON EXPANDED MIDDLE EAST PRESENCE NEW CENTERS IN DUBAI, KUWAIT, AND ABU DHA...
Více zde
NYXOAH FILES PATENT INFRINGEMENT LAWSUIT AGAINST INSPIRE MEDICAL SYSTEMS, INC.
15-09-2025
NYXOAH FILES PATENT INFRINGEMENT LAWSUIT AGAINST INSPIRE MEDICAL SYSTEMS, INC. MONT-SAINT-GUIBERT, B...
Více zde
PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS
05-09-2025
REGULATED INFORMATION PUBLICATION RELATING TO TRANSPARENCY NOTIFICATIONS MONT-SAINT-GUIBERT (BELGIUM...
Více zde
NYXOAH ANNOUNCES UPCOMING INVESTOR EVENTS
02-09-2025
NYXOAH ANNOUNCES UPCOMING INVESTOR EVENTS MONT-SAINT-GUIBERT, BELGIUM – SEPTEMBER 2, 2025, 10:30PM...
Více zde
NYXOAH REPORTS SECOND QUARTER FINANCIAL AND OPERATING RESULTS
18-08-2025
REGULATED INFORMATION NYXOAH REPORTS SECOND QUARTER FINANCIAL AND OPERATING RESULTS FDA APPROVES GEN...
Více zde
NYXOAH ANNOUNCES PRELIMINARY RESULTS FOR THE SECOND QUARTER OF 2025
11-08-2025
NYXOAH ANNOUNCES PRELIMINARY RESULTS FOR THE SECOND QUARTER OF 2025 MONT-SAINT-GUIBERT, BELGIUM – ...
Více zde
NYXOAH RECEIVES APPROVAL FROM FDA FOR GENIO® SYSTEM FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA
08-08-2025
INSIDE INFORMATION REGULATED INFORMATION NYXOAH RECEIVES APPROVAL FROM FDA FOR GENIO® SYSTEM FOR TH...
Více zde
NYXOAH TO RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 18, 2025
29-07-2025
NYXOAH TO RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 18, 2025...
Více zde
NYXOAH'S DREAM PIVOTAL STUDY DATA PUBLISHED IN THE JOURNAL OF CLINICAL SLEEP MEDICINE
28-07-2025
NYXOAH'S DREAM PIVOTAL STUDY DATA PUBLISHED IN THE JOURNAL OF CLINICAL SLEEP MEDICINE MONT-SAINT-GUI...
Více zde
INVITATION TO ATTEND THE EXTRAORDINARY SHAREHOLDERS' MEETING OF THE COMPANY TO BE HELD ON JULY 2, 2025
13-06-2025
REGULATED INFORMATION JUNE 13, 2025, 7:00AM CET / 1:00AM ET NYXOAH SA (EURONEXT BRUSSELS/NASDAQ: NYX...
Více zde
NYXOAH TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE
28-05-2025
NYXOAH TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE MONT-SAINT-GUIBERT, BELGIUM – MAY ...
Více zde
INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF NYXOAH S.A. - NYXH
16-05-2025
NEW YORK, NY / ACCESS NEWSWIRE / MAY 16, 2025 / NEW YORK, NY / ACCESSWIRE / MAY 14, 2025 / POMERANTZ...
Více zde
INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF NYXOAH S.A. - NYXH
14-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 14, 2025 / POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF...
Více zde
NYXOAH REPORTS FIRST QUARTER FINANCIAL AND OPERATING RESULTS
14-05-2025
REGULATED INFORMATION NYXOAH REPORTS FIRST QUARTER FINANCIAL AND OPERATING RESULTS COMPANY ON TRACK ...
Více zde
INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF NYXOAH S.A. – NYXH
13-05-2025
NEW YORK, MAY 13, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVEST...
Více zde
INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF NYXOAH S.A. - NYXH
12-05-2025
NEW YORK , MAY 12, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS...
Více zde
Dokumenty nejsou k dispozici
